CDC panel recommends U.S. resume use of J&J Covid vaccine, saying benefits outweigh risks
- A CDC advisory panel on Friday recommended the U.S. resume using the Johnson and Johnson Covid-19 vaccine.
- Members of the panel also proposed that the FDA include a warning label for women under age 50.
- The recommendation will pave the way for U.S. regulators to lift their recommended pause on using the J&J shot as early as this weekend.